A Study to Evaluate Safety, Tolerability, and Bioavailability of Subcutaneous Lirentelimab (AK002) in Adult Healthy Volunteers

Clinical trial NCT04324268 · COMPLETED

Trial details

NCT number: NCT04324268
Sponsor: Allakos Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Study Conducted in Healthy Volunteers

Start date: 2020-03-23
Primary completion: 2021-02-10
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.